Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-11-23 Purchase |
2021-11-26 1:30 pm |
Dermata Therapeutics Inc. | DRMA | PROEHL GERALD T President, CEO and Chairman 10% Owner |
20,000 | $2.4 | $48,000 | 3,180,465 (Indirect Direct) |
View |
| 2021-08-17 Purchase |
2021-08-17 12:49 pm |
Dermata Therapeutics Inc. | DRMA | HALE DAVID F Director 10% Owner |
35,714 | $0 | $0 | 90,329 (Indirect Direct) |
View |
| 2021-08-16 Purchase |
2021-08-17 12:38 pm |
Dermata Therapeutics Inc. | DRMA | PROEHL GERALD T President, CEO and Chairman 10% Owner |
152,857 | $0.32469 | $49,631 | 363,213 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-07-07 Option Award |
2022-07-08 4:10 pm |
N/A N/A |
Dermata Therapeutics Inc. | DRMA | FISHER MARY Director |
8,602 | $0 | 13,633 (Direct) |
View |
| 2022-07-01 Option Award |
2022-07-07 8:04 pm |
N/A 2032-06-30 |
Dermata Therapeutics Inc. | DRMA | Nardo Christopher J. Senior VP, CDO |
30,000 | $0 | 30,000 (Direct) |
View |
| 2022-04-07 Option Award |
2022-04-08 7:26 pm |
N/A N/A |
Dermata Therapeutics Inc. | DRMA | WIERENGA WENDELL Director |
10,593 | $0 | 15,471 (Direct) |
View |
| 2022-04-07 Option Award |
2022-04-08 7:19 pm |
N/A N/A |
Dermata Therapeutics Inc. | DRMA | FISHER MARY Director |
5,031 | $0 | 5,031 (Direct) |
View |
| 2022-04-07 Option Award |
2022-04-08 7:17 pm |
N/A N/A |
Dermata Therapeutics Inc. | DRMA | Scott Kathleen D. Director |
5,826 | $0 | 8,265 (Direct) |
View |
| 2022-04-07 Option Award |
2022-04-08 7:15 pm |
N/A N/A |
Dermata Therapeutics Inc. | DRMA | Sandler Andrew Seth Director |
5,190 | $0 | 5,190 (Direct) |
View |
| 2022-04-07 Option Award |
2022-04-08 7:13 pm |
N/A N/A |
Dermata Therapeutics Inc. | DRMA | Bradrick Brittany Director |
5,031 | $0 | 5,031 (Direct) |
View |
| 2022-04-07 Option Award |
2022-04-08 7:12 pm |
N/A N/A |
Dermata Therapeutics Inc. | DRMA | HALE DAVID F Director |
15,466 | $0 | 285,953 (Direct) |
View |
| 2022-01-12 Option Award |
2022-01-14 5:10 pm |
N/A 2032-01-11 |
Dermata Therapeutics Inc. | DRMA | Bradrick Brittany Director |
10,000 | $0 | 10,000 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-05 7:24 pm |
N/A 2032-01-02 |
Dermata Therapeutics Inc. | DRMA | Sandler Andrew Seth Director |
5,000 | $0 | 5,000 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-05 7:22 pm |
N/A 2032-01-02 |
Dermata Therapeutics Inc. | DRMA | Nardo Christopher J. Senior VP, Development |
30,000 | $0 | 30,000 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-05 7:15 pm |
N/A 2032-01-02 |
Dermata Therapeutics Inc. | DRMA | Van Hoose Kyri K. SVP, Chief Financial Officer |
30,000 | $0 | 30,000 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-05 7:08 pm |
N/A 2032-01-02 |
Dermata Therapeutics Inc. | DRMA | HALE DAVID F Director |
5,000 | $0 | 5,000 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-05 7:07 pm |
N/A 2032-01-02 |
Dermata Therapeutics Inc. | DRMA | WIERENGA WENDELL Director |
5,000 | $0 | 5,000 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-05 7:05 pm |
N/A 2032-01-02 |
Dermata Therapeutics Inc. | DRMA | Scott Kathleen D. Director |
5,000 | $0 | 5,000 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-05 7:03 pm |
N/A 2032-01-02 |
Dermata Therapeutics Inc. | DRMA | Mento Steven J Director |
5,000 | $0 | 5,000 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-05 7:01 pm |
N/A 2032-01-02 |
Dermata Therapeutics Inc. | DRMA | FISHER MARY Director |
5,000 | $0 | 5,000 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-05 6:59 pm |
N/A 2032-01-02 |
Dermata Therapeutics Inc. | DRMA | Bedoya-Toro Munera Maria E Senior Vice President |
15,000 | $0 | 15,000 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-05 6:58 pm |
2022-01-03 2032-01-02 |
Dermata Therapeutics Inc. | DRMA | PROEHL GERALD T President, CEO and Chairman 10% Owner |
302,127 | $0 | 302,127 (Direct) |
View |
| 2021-09-01 Option Award |
2021-09-01 8:32 pm |
N/A 2031-09-01 |
Dermata Therapeutics Inc. | DRMA | Van Hoose Kyri K. Chief Financial Officer |
75,000 | $0 | 75,000 (Direct) |
View |
| 2021-08-17 Option Award |
2021-08-17 12:52 pm |
N/A 2031-08-17 |
Dermata Therapeutics Inc. | DRMA | Mento Steven J Director |
10,000 | $0 | 10,000 (Direct) |
View |
| 2021-08-17 Conversion |
2021-08-17 12:51 pm |
N/A N/A |
Dermata Therapeutics Inc. | DRMA | Bedoya-Toro Munera Maria E Senior Vice President |
1,363,594 | $0 | 119,508 (Indirect) |
View |
| 2021-08-17 Conversion |
2021-08-17 12:49 pm |
N/A N/A |
Dermata Therapeutics Inc. | DRMA | HALE DAVID F Director 10% Owner |
5,433,001 | $0 | 90,329 (Indirect) |
View |
| 2021-08-17 Conversion |
2021-08-17 12:48 pm |
N/A N/A |
Dermata Therapeutics Inc. | DRMA | Proehl Investment Ventures LLC 10% Owner |
38,381,793 | $0 | 2,933,531 (Direct) |
View |
| 2021-08-17 Option Award |
2021-08-17 12:47 pm |
N/A 2031-08-17 |
Dermata Therapeutics Inc. | DRMA | Scott Kathleen D. Director |
10,000 | $0 | 10,000 (Direct) |
View |
| 2021-08-17 Conversion |
2021-08-17 12:45 pm |
N/A N/A |
Dermata Therapeutics Inc. | DRMA | WIERENGA WENDELL Director |
63,241 | $0 | 13,041 (Direct) |
View |
| 2021-08-17 Option Award |
2021-08-17 12:43 pm |
N/A 2031-08-17 |
Dermata Therapeutics Inc. | DRMA | Sandler Andrew Seth Director |
10,000 | $0 | 10,000 (Direct) |
View |
| 2021-08-17 Option Award |
2021-08-17 12:42 pm |
N/A 2031-08-17 |
Dermata Therapeutics Inc. | DRMA | FISHER MARY Director |
10,000 | $0 | 10,000 (Direct) |
View |
| 2021-08-17 Conversion |
2021-08-17 12:40 pm |
N/A N/A |
Dermata Therapeutics Inc. | DRMA | INSLEY THOMAS Chief Financial Officer |
35,491 | $0 | 14,337 (Indirect) |
View |
| 2021-08-17 Conversion |
2021-08-17 12:39 pm |
N/A N/A |
Dermata Therapeutics Inc. | DRMA | Nardo Christopher J. Senior VP, Development |
52,439 | $0 | 27,560 (Indirect) |
View |
| 2021-08-17 Conversion |
2021-08-17 12:38 pm |
N/A N/A |
Dermata Therapeutics Inc. | DRMA | PROEHL GERALD T President, CEO and Chairman 10% Owner |
38,866,391 | $0 | 363,213 (Indirect) |
View |
Ownership |
2021-08-12 7:47 pm |
N/A N/A |
Dermata Therapeutics Inc. | DRMA | Scott Kathleen D. Director |
0 | $0 | 2,439 (Indirect) |
View |
Ownership |
2021-08-12 7:43 pm |
N/A N/A |
Dermata Therapeutics Inc. | DRMA | Bedoya-Toro Munera Maria E Senior VP |
0 | $0 | 1,381,643 (Direct) |
View |
Ownership |
2021-08-12 7:42 pm |
N/A N/A |
Dermata Therapeutics Inc. | DRMA | Proehl Investment Ventures LLC 10% Owner |
0 | $0 | 37,282,896 (Direct) |
View |